Hyperinsulinemia, lipoprotein (a), and Chlamydia pneumoniae antibodies - Are they risk factors or serologic predictors for progression of coronary artery disease?
D. Tontsch et al., Hyperinsulinemia, lipoprotein (a), and Chlamydia pneumoniae antibodies - Are they risk factors or serologic predictors for progression of coronary artery disease?, ANGIOLOGY, 51(10), 2000, pp. 831-836
The authors studied 134 patients with unstable angina pectoris symptoms and
32 subjects without coronary artery disease (CAD) for the presence of clas
sical risk factors such as hypercholesterolemia, smoking, and family histor
y of CAD. In addition they analyzed plasma insulin levels, lipoprotein (a)
(Lp[a]) levels, and antibody titers against Chlamydia pneumoniae. All patie
nts had a heart catheterization. Patients with diabetes mellitus were exclu
ded from the study. Fasting insulin, low-density lipoprotein (LDL) choleste
rol and Chlamydia pneumoniae immunoglobulin G (IgG) and IgA antibody titers
did not show any difference in CAD from healthy control subjects, whereas
Lp(a) was increased and high-density lipoprotein (HDL) decreased in CAD pat
ients. These data indicate that lipoprotein (a), low HDL cholesterol, and s
moking, but neither hyperinsulinemia nor elevated Chlamydia pneumoniae tite
rs, are risk factors or predictors for CAD.